Since the pandemic began, sponsors have been implementing fully virtualized and hybrid trials out of necessity. This Insight Brief, authored by experts from Advanced Clinical, examines learnings from the pandemic, including case studies of successful use of virtual approaches to run more agile and adaptive trials. The authors explore how these advances may shape the future of drug development.
.png "Screenshot (1079)")